Clinical trial
Assessment of the Clinical Effect of Dialyzable Leukocyte Extracts in Individuals With Acute Respiratory Infection (Suspected or Confirmed Cases of COVID-19) (FUTURE-T)
NCT04379479 is registered in ClinicalTrials.gov with National Polytechnic Institute, Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Clinical Effect of Dialyzable Leukocyte Extracts in Individuals With Acute Respiratory Infection (Suspected or Confirmed Cases of COVID-19) (FUTURE-T)
- Lead sponsor
- National Polytechnic Institute, Mexico
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- May 31, 2020
- Completion date
- December 31, 2020
- Enrollment
- 562 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, sars-cov-2 infection